Friday 6 November 2026 Export TXG’s income statement to Excel — free account

10x Genomics

TXG Healthcare Medical Devices

10x Genomics' revenue for fiscal 2025 (year ended December 2025) was $642.8 million, up 5.25% from fiscal 2024.

Revenue: +1.12%
EPS: +31.8%
Free cash flow: −4.61%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

58.35 0.29 +0.50%

Follow TXG

Alert me

Market cap: $7.6B
P/E: 0.0×
Fwd P/E: −95.9×
Dividend yield: —
F-score: 6/9
Altman Z: 3.99
Beneish M: −3.23
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

10x Genomics (TXG) Book value per share

Alert me on Book value per share

10x Genomics's book value per share at the end of fiscal 2025 was 6.4×, up 8.27% from 5.9× in fiscal 2024. At the end of the quarter to 30 September 2026 it was 6.4×. Over the past ten years it has ranged from 0.0× (fiscal 2017) to 10.7× (fiscal 2019); the current reading is higher than 56% of that period. 10x Genomics ranks 47th of 149 Medical Devices companies by book value per share.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/TXG/book-value-per-share" width="100%" height="360" style="border:0" loading="lazy" title="10x Genomics book value per share, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/TXG/metrics/book-value-per-share">10x Genomics (TXG) book value per share — stockrow.com</a></p>

Period	Book value per share	Change
FY2025	6.4×	8.27%
FY2024	5.9×	(6.79%)
FY2023	6.3×	(10.63%)
FY2022	7.1×	(4.49%)
FY2021	7.4×	1.40%
FY2020	7.3×	(32.01%)
FY2019	10.7×	518.81%
FY2018	1.7×	—
FY2017	0.0×	—

Period	Book value per share	Change
Sep 2026	6.4×	0.88%
Jun 2026	6.4×	0.06%
Mar 2026	6.3×	(0.56%)
Dec 2025	6.4×	2.04%
29 more quarters	Free account

Against its own ten years

Low 0.0× High 10.7×

Ten-year median 6.4×

Current reading's percentile 56

Company	Book value per share
BIO.B Bio-Rad Laboratories, Inc. compare	284×
BIO Bio-Rad Laboratories, Inc. compare	284×
PEN Penumbra, Inc. compare	40.2×
GMED Globus Medical, Inc. compare	35.8×
PODD Insulet Corporation compare	22.8×
HAE Haemonetics Corporation compare	19.7×
BRKR Bruker Corporation compare	15.1×
TXG 10x Genomics	6.4×
SNN Smith & Nephew SNATS, Inc. compare	0.0×

What Book value per share is

BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.

(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))

The full definition of Book value per share →

10x Genomics (TXG) Book value per share

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on TXG

Book value per share, annual

Annual newest first

Quarterly newest first

Against its own ten years

Book value per share against peers

What Book value per share is

More on TXG

Stockrow Weekly